Lexicon Pharmaceuticals | LXRX - Ebitda





Ebitda Alterar Data
Abbott USD 2.43B 844M 2026-03
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
AstraZeneca USD 5.16B 510M 2026-06
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Coherus Biosciences USD -43.33M 4.7M 2025-09
Eli Lilly USD 10.29B 1.86B 2026-03
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Illumina USD 330M 80M 2026-06
Insmed USD -148.3M 165.88M 2026-03
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
J&J USD 8.27B 1.08B 2026-03
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
MacroGenics USD -30.2M 52.15M 2026-03
MannKind USD 2.93M 5.98M 2026-03
Merck USD -1.54B 7.84B 2026-03
Moderna USD -1.26B 468M 2026-03
Novartis USD 6.48B 1.19B 2026-06
PTC Therapeutics USD 61.98M 132.97M 2026-03
Puma Biotechnology USD 729K 11.36M 2024-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Thermo Fisher Scientific USD 3.55B 845M 2026-06
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
United Therapeutics USD 355M 11.1M 2026-06
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12